| Seliciclib | IC50 | 270.0 [1] |
| Staurosporine | IC50 | 1.2 [1], 3.8 [2], 4.0 [3], 10.0 [4], 100.0 [5] |
| Harmine | IC50 | 8000.0 [1], 10000.0 [2], 21000.0 [3] |
| Kenpaullone | IC50 | 849.18 [1], 850.0 [2], 1000.0 [3] |
| Indirubin | IC50 | 5000.0 [1], 5500.0 [2], 10000.0 [3] |
| 4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol | IC50 | 160.0 [1], 200.0 [2] |
| Alvocidib | IC50 | 60.0 [1], 170.0 [2] |
| 6-Bromoindirubin-3'-oxime | IC50 | 83.0 [1] |
| Indirubin-3'-monoxime | IC50 | 100.0 [1] |
| Alsterpaullone | IC50 | 39.99 [1], 40.0 [2], 330.0 [3] |
| 4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide | IC50 | 13.0 [1], 10000.0 [2] |
| 4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide | Ki | 18.0 [1] |
| Leucettine L41 | IC50 | 410.0 [1], 10000.0 [2], 30000.0 [3] |
| Leucettamine B | IC50 | 10000.0 [1], 100000.0 [2] |
| 1-(6-Oxo-2,3,4,10b-tetrahydro-1H-pyrido[2,1-a]isoindol-10-yl)-3-pyridin-2-ylurea | IC50 | 70.0 [1], 80.0 [2] |
| Doramapimod | IC50 | 30000.0 [1] |
| Dinaciclib | IC50 | 1.0 [1], 45.0 [2] |
| Purvalanol A | IC50 | 75.0 [1] |
| 1-Azakenpaullone | IC50 | 4200.0 [1] |
| Paullone | IC50 | 4200.0 [1], 10092.53 [2] |
| 4-(1H-Indol-3-yl)pyrimidin-2-amine | IC50 | 5000.0 [1], 140000.0 [2] |
| Aureusidin | IC50 | 3500.0 [1], 4810.0 [2] |
| 4-(5-Bromo-1H-indol-3-yl)pyrimidin-2-amine | IC50 | 1200.0 [1], 6000.0 [2] |
| 1-[2-(2,6-Dichlorobenzyl)-4-thiazolyl]-3-morpholinourea | IC50 | 1000.0 [1] |
| 1-[2-(2,6-Dichlorobenzyl)-4-thiazolyl]-3-morpholinourea | Ki | 500.0 [1] |
| 4-(4-Methoxy-1h-Pyrrolo[2,3-B]pyridin-3-Yl)pyrimidin-2-Amine | IC50 | 170.0 [1] |
| 4-(1H-Pyrrolo[2,3-B]pyridin-3-YL)pyrimidin-2-amine | IC50 | 510.0 [1] |
| (2R)-2-{[4-(Benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol | IC50 | 43.0 [1], 70.0 [2] |
| Meridianin D | IC50 | 1200.0 [1], 5500.0 [2] |
| Thieno analogue of kenpaullone | IC50 | 3999.45 [1], 4000.0 [2] |
| Hovetrichoside C | IC50 | 44440.0 [1], 50000.0 [2] |
| 6-Phenyl[5H]pyrrolo[2,3-b]pyrazine (aloisine) 37 | IC50 | 13000.0 [1] |
| 3-[4-(Pyridin-4-yl)-1,3-thiazol-2-yl]-1,2,3,4-tetrahydroquinazolin-2-one | IC50 | 77.0 [1] |
| 3-[2-(Pyridin-4-yl)-1,3-thiazol-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one | IC50 | 79.0 [1] |
| 3-(3-(Hydroxyimino)indolin-2-ylidene)-1-methylindolin-2-one | IC50 | 100000.0 [1] |
| 8-Methoxy-1-methyl-3,5-dihydropyridazino[4,5-b]indol-4-one | IC50 | 10000.0 [1] |
| {4-Amino-2-[(4-Chlorophenyl)amino]-1,3-Thiazol-5-Yl}(3-Nitrophenyl)methanone | IC50 | 750.0 [1], 2000.0 [2] |
| N-(2-(Dimethylamino)ethyl)-8-isopropyl-9-oxo-8,9-dihydrothiazolo[5,4-f]quinazoline-2-carboxamidine | IC50 | 4000.0 [1] |
| 4-(4-Propoxy-1h-Pyrrolo[2,3-B]pyridin-3-Yl)pyrimidin-2-Amine | IC50 | 3.0 [1] |
| Meriolin 9 | IC50 | 10000.0 [1], 73000.0 [2] |
| Meriolin 2 | IC50 | 50.0 [1] |
| 2-(1-Methyl-2-oxoindolin-3-ylidene)indolin-3-one | IC50 | 100000.0 [1] |
| 6-Hydroxy-3-methoxy-4-phenylbenzo[4,3-b]pyridine | IC50 | 6300.0 [1] |
| 6-Hydroxy-3-methoxy-4-phenylbenzo[4,3-b]pyridine | Ki | 217000.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 1-(6-Oxo-2,3,4,10b-tetrahydro-1H-pyrido[2,1-a]isoindol-10-yl)-3-pyrazin-2-ylurea | IC50 | 70.0 [1], 80.0 [2] |
| 6-Methyl-N-[3-[4-[(2-naphthalen-1-ylacetyl)amino]imidazol-1-yl]cyclobutyl]pyridine-2-carboxamide | IC50 | 6.0 [1], 230.0 [2] |
| 6-Chloro-N-[3-[4-[(2-naphthalen-1-ylacetyl)amino]imidazol-1-yl]cyclobutyl]pyridine-2-carboxamide | IC50 | 6.0 [1], 673.0 [2] |
| N-[3-[4-[(2-Naphthalen-1-ylacetyl)amino]imidazol-1-yl]cyclobutyl]pyridine-2-carboxamide | IC50 | 14.0 [1], 1300.0 [2] |
| 7-(Morpholin-4-ylmethyl)-3-[2-(pyridin-4-yl)-1,3-thiazol-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one | IC50 | 62.0 [1] |
| (5Z)-2-(2-Aminoethylimino)-5-(1,3-benzodioxol-5-ylmethylidene)-3-methylimidazolidin-4-one | IC50 | 910.0 [1], 100000.0 [2] |
| 2-[(E)-2-(2,6-Dichlorophenyl)ethenyl]-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one | IC50 | 15.5 [1], 15.7 [2] |
| N-[3-[6-[(4-Acetamidocyclohexyl)amino]purin-9-yl]cyclobutyl]-6-methylpyridine-2-carboxamide | IC50 | 27.0 [1], 30.0 [2] |
| N-[1-(cis-3-Hydroxycyclobutyl)-1H-imidazol-4-yl]-2-(4-methoxyphenyl)acetamide | IC50 | 95.0 [1], 1090.0 [2] |
| 3-(6-Chloro-5-fluoro-1-methylindol-3-yl)-4-[6-(hydroxymethyl)-1-benzofuran-3-yl]pyrrole-2,5-dione | IC50 | 16100.0 [1], 18900.0 [2] |
| 3-(6-Chloro-5-fluoro-1-methylindol-3-yl)-4-(7-methoxy-1-benzofuran-3-yl)pyrrole-2,5-dione | IC50 | 61600.0 [1], 108000.0 [2] |
| 3-(5-Bromo-1-methyl-1H-indol-3-yl)-4-(6-hydroxymethylbenzofuran-3-yl)pyrrole-2,5-dione | IC50 | 1130.0 [1], 1160.0 [2] |
| 3-Benzofuran-3-yl-4-(7-methoxymethyl-1-methyl-1H-indol-3-yl)pyrrole-2,5-dione | IC50 | 12700.0 [1], 12900.0 [2] |
| Methyl 3-[4-[[2-(4-methoxyphenyl)acetyl]amino]imidazol-1-yl]cyclobutane-1-carboxylate | IC50 | 145.0 [1], 4380.0 [2] |
| N-[1-(3-Acetamidocyclobutyl)imidazol-4-yl]-2-naphthalen-1-ylacetamide | IC50 | 8.0 [1], 30000.0 [2] |
| N-[3-[4-[(2-Naphthalen-1-ylacetyl)amino]imidazol-1-yl]cyclobutyl]pyridine-3-carboxamide | IC50 | 46.0 [1], 30000.0 [2] |
| Aureusidin 6-O-beta-glucoside | IC50 | 22320.0 [1], 24330.0 [2] |
| 6-Methoxy-4-phenyl-3-phenylmethoxy-[1]benzofuro[2,3-b]pyridine | Ki | 25100.0 [1], 26100.0 [2] |
| 7-Methyl-4-phenyl-3-phenylmethoxy-[1]benzofuro[2,3-b]pyridin-6-ol | Ki | 25300.0 [1] |
| 12-Phenyl-13-phenylmethoxy-17-oxa-15-azatetracyclo[8.7.0.02,7.011,16]heptadeca-1(10),2,4,6,8,11,13,15-octaen-8-ol | Ki | 2100.0 [1] |
| 7-Fluoro-3-[2-(pyridin-4-yl)-1,3-thiazol-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one | IC50 | 16.0 [1] |
| Quercetin | IC50 | 23000.0 [1] |
| Apigenin | IC50 | 1600.0 [1] |
| Kaempferol | IC50 | 51000.0 [1] |
| Luteolin | IC50 | 3800.0 [1] |
| Chrysin | IC50 | 3100.0 [1] |
| Indigo | IC50 | 100000.0 [1] |
| Fisetin | IC50 | 570.0 [1] |
| Palbociclib | IC50 | 10000.0 [1] |
| Olomoucine | IC50 | 7000.0 [1] |
| Hyperoside | IC50 | 10280.0 [1] |
| Abemaciclib | IC50 | 405.0 [1] |
| N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-YL)urea | IC50 | 100000000.0 [1] |
| Purvalanol B | IC50 | 6.0 [1] |
| Fascaplysin | IC50 | 20000.0 [1] |
| Sns-032 | IC50 | 340.0 [1] |
| Manzamine A | IC50 | 1500.0 [1] |
| Sulfuretin | IC50 | 37030.0 [1] |
| Hymenialdisine | IC50 | 28.0 [1] |
| Milciclib | IC50 | 265.0 [1] |
| Cercosporamide | IC50 | 5600.0 [1] |
| Amg-458 | IC50 | 100000.0 [1] |
| Olomoucine II | IC50 | 270.0 [1] |
| Pha-793887 | IC50 | 5.0 [1] |
| Cupressuflavone | IC50 | 9290.0 [1] |
| BS-181 | IC50 | 3700.0 [1] |
| 7-Bromo-3-[3-(hydroxyamino)-1H-indol-2-yl]indol-2-one | IC50 | 33000.0 [1] |
| 3-(2-Aminopyrimidin-4-yl)-1H-indol-4-ol | IC50 | 3000.0 [1] |
| RGB-286638 free base | IC50 | 2.0 [1] |
| 1,3,5,8-Tetrahydroxyxanthone | IC50 | 200.0 [1] |
| N-(3-Chloro-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine | IC50 | 10000.0 [1] |
| (3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide | IC50 | 4960.0 [1] |
| Nms-P937 (nms1286937) | IC50 | 10000.0 [1] |
| Indirubin deriv. 8a | IC50 | 2400.0 [1] |